NCT01662830

Brief Summary

The primary aim of this study is to to retrospectively evaluate the efficacy of the MWCC Jump Start (Medifast's 5 \& 1) Plan on the following indices: weight loss, anthropometric changes, and reduction in common markers of coronary heart disease.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
446

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 10, 2012

Completed
Last Updated

August 10, 2012

Status Verified

August 1, 2012

Enrollment Period

1.9 years

First QC Date

August 3, 2012

Last Update Submit

August 8, 2012

Conditions

Keywords

ObesityMeal replacements

Outcome Measures

Primary Outcomes (2)

  • Changes in weight

    Weight loss (in pounds and percent weight loss) at weeks 4, 12, 24 and at final weight loss visit (average of 19.6 weeks).

    weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)

  • Changes in body composition

    changes in lean muscle mass, body fat mass, and body fat percent at weeks 4, 12, 24, and final weight loss visit(average of 19.6 weeks).

    weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)

Secondary Outcomes (6)

  • Compliance

    weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)

  • Retention rates

    weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)

  • Goal weight achievement

    Final weight loss visit (average of 19.6 weeks)

  • Changes in abdominal circumference (inches)

    weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)

  • Maintenance of weight loss

    Following transition (up to 12 weeks) and maintenance (up to 52 weeks) phases of the program

  • +1 more secondary outcomes

Study Arms (1)

MWCC clients

This study will be a systematic retrospective chart review of clients participating in the Jump Start (5 \& 1) Plan at three different MWCC locations in Texas during the years 2007 - 2010.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study was a systematic retrospective chart review of patients participating in the Jump Start (5 \& 1) Plan at three different MWCC locations in Texas during the years 2007-2010.

You may qualify if:

  • Adult males and females aged 18-70
  • Followed the Jump Start (5 \& 1) Plan
  • BMI ≥ 25
  • Purchased a weight management program at the MWCC location in the last 3 years
  • Signed patient health information consent form

You may not qualify if:

  • On a plan other than the 5\&1 (Jump Start)
  • Completed initial consultation but did not participate further
  • Program stopped due to client not getting baseline labs
  • Program stopped due for medical reasons unrelated to the 5 \& 1 (Jump Start) plan
  • Currently an active participant at the MWCC
  • No signed patient health information consent form or written request to revoke consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003 May;27(5):537-49. doi: 10.1038/sj.ijo.0802258.

    PMID: 12704397BACKGROUND
  • Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008 Jun;13(2):95-101. doi: 10.1007/BF03327609.

    PMID: 18612258BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2012

First Posted

August 10, 2012

Study Start

April 1, 2010

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

August 10, 2012

Record last verified: 2012-08